Australian Clinical Labs Ltd (AU:ACL) has released an update.
First Sentier Investors has ceased to be a substantial holder in Australian Clinical Labs Ltd as of May 28, 2024, with the previous notice provided on May 20, 2024. Details of the changes in relevant interests and associates in voting securities of the company were documented in the formal notice signed on May 30, 2024. The announcement includes a list of entities associated with First Sentier Investors and their respective changes in association.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.
